Howard Capital Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
10,681
-2,000
-16% -$52.3K 0.02% 124
2026
Q1
$356K Sell
12,681
-1,200
-9% -$31.9K 0.02% 101
2025
Q4
$346K Hold
13,881
0.02% 102
2025
Q3
$354K Hold
13,881
0.02% 105
2025
Q2
$336K Hold
13,881
0.02% 100
2025
Q1
$352K Hold
13,881
0.03% 93
2024
Q4
$368K Hold
13,881
0.03% 95
2024
Q3
$402K Hold
13,881
0.03% 92
2024
Q2
$388K Hold
13,881
0.03% 90
2024
Q1
$385K Hold
13,881
0.03% 91
2023
Q4
$400K Hold
13,881
0.03% 79
2023
Q3
$460K Hold
13,881
0.04% 69
2023
Q2
$509K Hold
13,881
0.05% 69
2023
Q1
$566K Buy
13,881
+5,443
+65% +$235K 0.06% 65
2022
Q4
$432K Sell
8,438
-500
-6% -$24K 0.05% 67
2022
Q3
$391K Hold
8,938
0.05% 69
2022
Q2
$469K Hold
8,938
0.06% 63
2022
Q1
$463K Hold
8,938
0.04% 72
2021
Q4
$528K Buy
8,938
+1,548
+21% +$76.7K 0.04% 70
2021
Q3
$318K Hold
7,390
0.03% 87
2021
Q2
$289K Hold
7,390
0.03% 92
2021
Q1
$268K Buy
+7,390
New +$262K 0.03% 82

Other funds holding PFE

Howard Capital Management Group's PFE Position: Q2 2026 in Review

Howard Capital Management Group reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $52.3K and leaving 10,681 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #124.

Howard Capital Management Group first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $566K in Q1 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Howard Capital Management Group held 10,681 shares of Pfizer worth $257K as of Q2 2026.
  • Howard Capital Management Group sold 2,000 Pfizer shares in Q2 2026, an estimated $52.3K.
  • Pfizer made up 0.02% of Howard Capital Management Group's portfolio in Q2 2026, its #124 holding.
  • Howard Capital Management Group first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
  • Howard Capital Management Group's Pfizer position peaked at $566K in Q1 2023.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.